Hypoglycemia: An overview of fear of hypoglycemia, quality-of-life, and impact on costs

Journal of Medical Economics

Volumn 14, Issue 5, 2011, Pages 646-655

  Fidler, Carrie ^a   Elmelund Christensen, Torsten ^b   Gillard, Samantha ^a  

^a Decision Resources Group   (United Kingdom)

^b NOVO NORDISK A S   (Denmark)

Author keywords

Diabetes; Fear of hypoglycemia; Glycemic control; Healthcare costs; Hypoglycemia; Quality of life; Utility

Indexed keywords

GLUCOSE; INSULIN; INSULIN DETEMIR; INSULIN GLARGINE; ISOPHANE INSULIN;

ABSENTEEISM; ANXIETY; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; COST UTILITY ANALYSIS; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE SEVERITY; FEAR; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH CARE COST; HEALTH CARE SYSTEM; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MEDICAL DECISION MAKING; MEDLINE; NOCTURNAL HYPOGLYCEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRODUCTIVITY; QUALITY OF LIFE; REVIEW; SOCIETY; WELLBEING;

COSTS AND COST ANALYSIS; FEAR; HEALTH CARE COSTS; HYPOGLYCEMIA; QUALITY OF LIFE;

EID: 80052723424     PISSN: 13696998     EISSN: 1941837X     Source Type: Journal    
DOI: 10.3111/13696998.2011.610852     Document Type: Review

References (54)

1. U.K. Prospective Diabetes Study Group. Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). Diabetes Care 1999;22:1125-36
2. Rubin RR, Peyrot M. Quality of life and diabetes. Diabetes Metab Res Rev 1999;15:205-18
3. Gray A, Raikou M, McGuire A, et al. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: Economic analysis alongside randomised controlled trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group. BMJ 2000;320:1373-8
4. Klonoff DC, Schwartz DM. An economic analysis of interventions for diabetes. Diabetes Care 2000;23:390-404
5. Hypoglycemia in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. Diabetes 1997; 46:271-86
6. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-53
7. Hepburn DA. Symptoms of hypoglycemia. In: Frier BM, ed. Hypoglycemia and diabetes: Clinical and physiological aspects. London: Edward Arnold, 1993:93-103
8. Cryer PE. Hypoglycemia: Pathophysiology, diagnosis and treatment. New York: Oxford University Press, 1997
9. Defining and reporting hypoglycemia in diabetes: A report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 2005;28: 1245-9
10. Donnelly LA, Morris AD, Frier BM, et al. Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: A population-based study. Diabet Med 2005;22:749-55
11. Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care 2003;26:1902-12
12. Heller S, Chapman J, McCloud J, et al. Unreliability of reports of hypoglycaemia by diabetic patients. BMJ 1995;310:440
13. Leiter LA, Yale JF, Chiasson JL, et al. Assessment of the impact of fear of hypoglycemic episodes on glycemic and hypoglycemia management. Can J Diabetes 2005;29:186-92
14. Allen KV, Frier BM. Nocturnal hypoglycemia: Clinical manifestations and therapeutic strategies toward prevention. Endocr Pract 2003;9:530-43
15. Veneman T, Mitrakou A, Mokan M, et al. Induction of hypoglycemia unawareness by asymptomatic nocturnal hypoglycemia. Diabetes 1993;42:1233-7
16. Sovik O, Thordarson H. Dead-in-bed syndrome in young diabetic patients. Diabetes Care 1999;22(2 Suppl):40-2
17. Wild D, von Maltzahn R, Brohan E, et al. A critical review of the literature on fear of hypoglycemia in diabetes: Implications for diabetes management and patient education. Patient Educ Couns 2007;68:10-5
18. Cox DJ, Irvine A, Gonder-Frederick L, et al. Fear of hypoglycemia: Quantification, validation, and utilization. Diabetes Care 1987;10:617-21
19. Irvine AA, Cox D, Gonder-Frederick L. Fear of hypoglycemia: Relationship to physical and psychological symptoms in patients with insulin-dependent diabetes mellitus. Health Psychol 1992;11:135-8
20. Polonsky WH, Davis CL, Jacobson AM, et al. Correlates of hypoglycemic fear in type I and type II diabetes mellitus. Health Psychol 1992;11:199-202
21. Sauriol L, Yale JF, Ciasson JL, et al. Fear of hypoglycaemia in people with type 1 and type 2 diabetes: The AID hypo on QoL study. 2006. Available at: Http://www.katalyst.on.ca/documents/CDA1Poster.pdf. Accessed October 15, 2010
22. Brod M, Christensen T, Thomsen TL, et al. The impact of non-severe hypoglycemic events on diabetes management and work productivity. Value in Health 2011; (in press
23. Barnard K, Thomas S, Royle P, et al. Fear of hypoglycaemia in parents of young children with type 1 diabetes: A systematic review. BMC Pediatr 2010;10:50
24. Haugstvedt A, Wentzel-Larsen T, Graue M, et al. Fear of hypoglycaemia in mothers and fathers of children with Type 1 diabetes is associated with poor glycaemic control and parental emotional distress: A population-based study. Diabet Med 2010;27:72-8
25. Patton SR, Dolan LM, Henry R, et al. Fear of hypoglycemia in parents of young children with type 1 diabetes mellitus. J Clin Psychol Med Settings 2008;15:252-9
26. Lundkvist J, Berne C, Bolinder B, et al. The economic and quality of life impact of hypoglycemia. Eur J Health Econ 2005;6:197-202
27. Frier BM. How hypoglycaemia can affect the life of a person with diabetes. Diabetes Metab Res Rev 2008;24:87-92
28. Levy AR, Christensen TL, Johnson JA. Utility values for symptomatic nonsevere hypoglycaemia elicited from persons with and without diabetes in Canada and the United Kingdom. Health Qual Life Outcomes 2008;6:73
29. Costea M, Ionescu-Tirgoviste C, Cheta D, et al. Fear of hypoglycemia in type 1 (insulin-dependent) diabetic patients. Rom J Intern Med 1993;31:291-5
30. Marrett E, Stargardt T, Mavros P, et al. Patient-reported outcomes in a survey of patients treated with oral antihyperglycaemic medications: Associations with hypoglycaemia and weight gain. Diabetes Obes Metab 2009;11: 1138-44
31. Matza LS, Boye KS, Yurgin N, et al. Utilities and disutilities for type 2 diabetes treatment-related attributes. Qual Life Res 2007;16:1251-65
32. Davis RE, Morrissey M, Peters JR, et al. Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes. Curr Med Res Opin 2005;21:1477-83
33. Alvarez-Guisasola F, Yin DD, Nocea G, et al. Association of hypoglycemic symptoms with patients' rating of their health-related quality of life state: A cross sectional study. Health Qual Life Outcomes 2010;8:86
34. Solli O, Stavem K, Kristiansen IS. Health-related quality of life in diabetes: The associations of complications with EQ-5D scores. Health Qual Life Outcomes 2010;8:18
35. Currie CJ, Morgan CL, Poole CD, et al. Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes. Curr Med Res Opin 2006;22:1523-34
36. Warren E, Weatherley-Jones E, Chilcott J, et al. Systematic review and economic evaluation of a long-acting insulin analogue, insulin glargine. Health Technol Assess 2004;8:iii,1-57
37. Jonsson L, Bolinder B, Lundkvist J. Cost of hypoglycemia in patients with Type 2 diabetes in Sweden. Value Health 2006;9:193-8
38. Harris SB, Leiter LA, Yale JF, et al. Out-of-pocket costs of managing hyperglycemia and hypoglycemia in patients with type 1 diabetes and insulintreated type 2 diabetes. Can J Diabetes 2007;31:25-33
39. Farmer A, Balman E, Gadsby R, et al. Frequency of self-monitoring of blood glucose in patients with type 2 diabetes: Association with hypoglycaemic events. Curr Med Res Opin 2008;24:3097-3104
40. Hansen MV, Pedersen-Bjergaard U, Heller SR, et al. Frequency and motives of blood glucose self-monitoring in type 1 diabetes. Diabetes Res Clin Pract 2009;85:183-8
41. Reviriego J, Gomis R, Maranes JP, et al. Cost of severe hypoglycaemia in patients with type 1 diabetes in Spain and the cost-effectiveness of insulin lispro compared with regular human insulin in preventing severe hypoglycaemia. Int J Clin Pract 2008;62:1026-32
42. Whitmer RA, Karter AJ, Yaffe K,et al. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 2009;301:1565-72
43. Johnston SS, Conner C, Aagren M, et al. Evidence linking hypoglycemic events to an increased risk of acute cardiovascular events in patients with type 2 diabetes. Diabetes Care 2011;34:1164-70
44. Hermanns N, Kulzer B, Krichbaum M, et al. Long-term effect of an education program (HyPOS) on the incidence of severe hypoglycemia in patients with type 1 diabetes. Diabetes Care 2010;33:e36
45. Nordfeldt S, Johansson C, Carlsson E, et al. Prevention of severe hypoglycaemia in type I diabetes: A randomised controlled population study. Arch Dis Child 2003;88:240-5
46. Svoren BM, Butler D, Levine BS, et al. Reducing acute adverse outcomes in youths with type 1 diabetes: A randomized, controlled trial. Pediatrics 2003;112:914-22
47. Bullano MF, Al-Zakwani IS, Fisher MD, et al. Differences in hypoglycemia event rates and associated cost-consequence in patients initiated on longacting and intermediate-acting insulin products. Curr Med Res Opin 2005;21:291-8
48. Gschwend MH, Aagren M, Valentine WJ. Cost-effectiveness of insulin detemir compared with neutral protamine Hagedorn insulin in patients with type 1 diabetes using a basal-bolus regimen in five European countries. J Med Econ 2009;12:114-23
49. Vexiau P, Mavros P, Krishnarajah G, et al. Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France. Diabetes Obes Metab 2008;10(Suppl 1):16-24
50. Heaton A, Martin S, Brelje T. The economic effect of hypoglycemia in a health plan. Manag Care Interface 2003;16:23-7
51. Leese GP, Wang J, Broomhall J, et al. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: A populationbased study of health service resource use. Diabetes Care 2003;26:1176-80
52. Curkendall SM, Natoli JL, Alexander CM, et al. Economic and clinical impact of inpatient diabetic hypoglycemia. Endocr Pract 2009;15:302-12
53. Hammer M, Lammert M, Mejias SM, et al. Costs of managing severe hypoglycaemia in three European countries. J Med Econ 2009;12:281-90
54. Rhoads GG, Orsini LS, Crown W, et al. Contribution of hypoglycemia to medical care expenditures and short-term disability in employees with diabetes. J Occup Environ Med 2005;47:447-52